Lung cancer is the leading cause of cancer death worldwide. Non-small
lung cell cancer (NSCLC) is the most common form of lung cancer. Although new
therapies have considerably improved survival, patients rarely survive for more
than 5 years. There is a tremendous need for a better understanding of the
molecular and genetic mechanisms of the disease.
The aim of the Lung Cell Laboratory is to investigate the molecular
mechanisms controlling proliferation and apoptosis of NSCLC cells and to
elucidate the role of their microenvironment. Our research is focussing on
oxygen and substrate availability, and on metabolic and epigenetic changes.
I am proud that in our laboratory, dedicated scientists and a number of
excellent technicians and students have pioneered this challenging research
field.
Horst
Olschewski, MD, Professor
of Medicine, Director, Div. Pulmonology
Hrzenjak Group Members and projects
Leithner Group Members and projects
f. l. Katharina Leithner, Priv.-Doz. Dr. med. PhD, Andelko Hrzenjak, Assoc. Prof. PhD., Alexandra Bertsch, MSc.
m. l. Elisabeth Smolle, Dr. med., Irina Fadejeva, Dr. med., Carina Seidl, BSc.
b. l. Felix Prinz, BSc., Gabriele Grasmann, MSc., Katrin Panzitt, PhD.
Copyright: @Andelko Hrzenjak